Key facts
- This page summarizes Eric E. Poma's Form 3 filing for Calidi Biotherapeutics, Inc. (CLDI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 25 Apr 2025, 06:01.
Eric E. Poma - 22 Apr 2025 Form 3 Insider Report for Calidi Biotherapeutics, Inc. (CLDI)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- CLDI
- Reported as of
- 22 Apr 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 25 Apr 2025, 06:01:32 UTC
- Prior SEC filing
- 25 Jan 2024
- Next SEC filing
- 25 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Poma
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric E. Poma filed Form 3 for Calidi Biotherapeutics, Inc. (CLDI) on 25 Apr 2025.
Change
- Previous filing in this sequence was filed on 25 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.